Want to see IL:NRGN full AI Analyst Report?
Nrgene (NRGN) Financial Statements
Nrgene Financial Overview
Nrgene's market cap is currently $9.24M. The company's EPS TTM is $-0.20; its P/E ratio is -1.12; Nrgene is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.17M | $ 1.29M | $ 2.00M | $ 3.16M | $ 4.46M |
| Gross Profit | $ 1.92M | $ 267.00K | $ 901.00K | $ 1.71M | $ 2.46M |
| Operating Income | $ -1.57M | $ -3.31M | $ -5.28M | $ -5.36M | $ -8.40M |
| EBITDA | $ -965.00K | $ -2.69M | $ -4.53M | $ -5.59M | $ -8.10M |
| Net Income | $ -1.50M | $ -3.36M | $ -5.24M | $ -6.21M | $ -8.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.30M | $ 1.37M | $ 6.45M | $ 12.28M | $ 22.87M |
| Total Assets | $ 9.54M | $ 6.00M | $ 10.79M | $ 17.30M | $ 26.36M |
| Total Debt | $ 181.00K | $ 288.00K | $ 797.00K | $ 1.61M | $ 3.34M |
| Net Debt | $ -3.96M | $ -1.00M | $ -5.65M | $ -10.67M | $ -5.51M |
| Total Liabilities | $ 5.13M | $ 2.00M | $ 3.57M | $ 5.04M | $ 8.68M |
| Stockholders' Equity | $ 4.31M | $ 3.96M | $ 7.21M | $ 12.26M | $ 17.68M |
| Cash Flow | |||||
| Free Cash Flow | $ 72.00K | $ -5.19M | $ -5.58M | $ -7.83M | $ -6.67M |
| Operating Cash Flow | $ 855.00K | $ -3.56M | $ -3.91M | $ -6.12M | $ -5.57M |
| Investing Cash Flow | $ 455.00K | $ -1.30M | $ -1.27M | $ 12.47M | $ -14.83M |
| Financing Cash Flow | $ 1.53M | $ -317.00K | $ -410.00K | $ -2.46M | $ 27.59M |
Currency in USD